MétaCan
Menu
Back to cohort
Record W2951964351 · doi:10.21693/1933-088x-7.1.206a

Introducing CME Credit– and More Dynamic Content

2008· article· en· W2951964351 on OpenAlexaboutno aff
Ronald J. Oudiz

Bibliographic record

VenueAdvances in Pulmonary Hypertension · 2008
Typearticle
Languageen
FieldMedicine
TopicPulmonary Hypertension Research and Treatments
Canadian institutionsnot available
Fundersnot available
KeywordsGlobeContinuing medical educationMedicineQuarter (Canadian coin)Pulmonary hypertensionMedical educationPolitical scienceFamily medicineContinuing educationCardiologyHistoryOphthalmology

Abstract

fetched live from OpenAlex

This first-quarter 2008 issue marks the first time Advances in Pulmonary Hypertension will be offering continuing medical education (CME) credit. We are pleased to make this service available through the University of Michigan Medical School. Upon completing the questions related to each topic, readers will be able to claim up to 2.0 hours of CME credit while learning the latest about pulmonary hypertension. This issue also kicks off our new International Corner, with an initial commentary by Adam Torbicki, MD, PhD, of Warsaw, Poland. His thoughts on the fourth-quarter 2007 issue are provided in English and Polish.It is hoped that these exciting additions will help further the study of pulmonary hypertension across the globe. Working toward this goal, I hope you will join me at PHA's Eighth International PH Conference and Scientific Sessions this June in Houston, Texas. With more than 60 scientific and clinical posters, four presentations by distinguished investigators, and sessions for patients and family members, this Conference is unique and not to be missed.James Maloney, MD, the lead Guest Editor for this issue, with the assistance of Todd Bull, MD, superbly edited the leading-edge content covering medical management, clinical trials, and combination therapies. The first article by Jeremiah Depta, MD, and Richard Krasuski, MD, reviews the recently updated American College of Chest Physicians guidelines on medical management of pulmonary arterial hypertension. The article by Zeenat Safdar, MD, covers ongoing phase 2 and phase 3 clinical trials that are likely to be completed soon and will potentially provide evidence for new treatment options. Ioana R. Preston, MD, a member of the Advances in Pulmonary Hypertension Editorial Board, covers the ever-changing and often contested spectrum of combination drug therapy for pulmonary arterial hypertension. This paper is a comprehensive summary of available and emerging evidence, mostly in support of using at least two different PAH drugs for additive and perhaps synergistic effects on the pulmonary circulation.Finally, a Roundtable Discussion led by Karen Fagan, MD, covers an increasingly important consideration, namely, the use of pulmonary arterial hypertension therapy in a broader group of patients than have been studied to date. This has important implications for the patients in question, and also for future patient groups to be targeted for treatment with PAH-specific drugs. Panel members included Kamal K. Mubarak, MD, Zeenat Safdar, MD, Aaron Waxman, MD, PhD, and Roham T. Zamanian, MD.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.328
Threshold uncertainty score0.854

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.001
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.030
GPT teacher head0.292
Teacher spread0.261 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2008
Admission routes1
Has abstractyes

Explore more

Same venueAdvances in Pulmonary HypertensionSame topicPulmonary Hypertension Research and TreatmentsFrench-language works237,207